SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cytrx Corp – ‘10-K’ for 12/31/19 – ‘EX-101.SCH’

On:  Friday, 3/27/20, at 6:21am ET   ·   For:  12/31/19   ·   Accession #:  1493152-20-4848   ·   File #:  0-15327

Previous ‘10-K’:  ‘10-K’ on 3/29/19 for 12/31/18   ·   Next:  ‘10-K’ on 3/24/21 for 12/31/20   ·   Latest:  ‘10-K’ on 3/27/24 for 12/31/23   ·   1 Reference:  By:  LadRx Corp. – ‘S-8’ on 10/23/20

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/27/20  Cytrx Corp                        10-K       12/31/19   71:12M                                    M2 Compliance/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    699K 
 2: EX-10.4.3   Material Contract                                   HTML     23K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML     22K 
 4: EX-23.2     Consent of Experts or Counsel                       HTML     23K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
25: R1          Document and Entity Information                     HTML     57K 
50: R2          Consolidated Balance Sheets                         HTML     93K 
64: R3          Consolidated Balance Sheets (Parenthetical)         HTML     50K 
38: R4          Consolidated Statements of Operations               HTML     83K 
26: R5          Consolidated Statements of Stockholders' Equity     HTML     49K 
51: R6          Consolidated Statements of Cash Flows               HTML    116K 
65: R7          Nature of Business                                  HTML     39K 
35: R8          Summary of Significant Accounting Policies          HTML     53K 
28: R9          Discontinued Operations                             HTML     36K 
52: R10         Foreign Currency Remeasurement                      HTML     25K 
69: R11         Equipment and Furnishings                           HTML     27K 
32: R12         Accrued Expenses and Other Current Liabilities      HTML     28K 
22: R13         Leases                                              HTML     31K 
53: R14         Commitments and Contingencies                       HTML     34K 
70: R15         Equity Transactions                                 HTML     24K 
33: R16         Stock Options and Equity-Classified Warrants        HTML     94K 
23: R17         Stockholder Protection Rights Plan                  HTML     32K 
54: R18         Income Taxes                                        HTML     42K 
68: R19         Subsequent Events                                   HTML     25K 
46: R20         Summary of Significant Accounting Policies          HTML     95K 
                (Policies)                                                       
19: R21         Summary of Significant Accounting Policies          HTML     29K 
                (Tables)                                                         
58: R22         Discontinued Operations (Tables)                    HTML     39K 
62: R23         Equipment and Furnishings (Tables)                  HTML     27K 
47: R24         Accrued Expenses and Other Current Liabilities      HTML     27K 
                (Tables)                                                         
20: R25         Leases (Tables)                                     HTML     26K 
59: R26         Commitments and Contingencies (Tables)              HTML     27K 
63: R27         Stock Options and Equity-Classified Warrants        HTML    102K 
                (Tables)                                                         
45: R28         Income Taxes (Tables)                               HTML     39K 
21: R29         Nature of Business (Details Narrative)              HTML     54K 
29: R30         Summary of Significant Accounting Policies          HTML     54K 
                (Details Narrative)                                              
36: R31         Summary of Significant Accounting Policies -        HTML     28K 
                Schedule of Fair Value Measurements by Level for                 
                Assets and Liabilities Measured at Fair Value on a               
                Recurring Basis (Details)                                        
67: R32         Discontinued Operations (Details Narrative)         HTML     46K 
49: R33         Discontinued Operations - Schedule of Discontinued  HTML     66K 
                Operations (Details)                                             
27: R34         Foreign Currency Remeasurement (Details Narrative)  HTML     24K 
34: R35         Equipment and Furnishings (Details Narrative)       HTML     24K 
66: R36         Equipment and Furnishings - Schedule of Equipment   HTML     31K 
                and Furnishings (Details)                                        
48: R37         Accrued Expenses and Other Current Liabilities -    HTML     38K 
                Schedule of Accrued Expenses and Other Current                   
                Liabilities (Details)                                            
24: R38         Leases (Details Narrative)                          HTML     32K 
37: R39         Leases - Schedule of Rent Expense and Supplemental  HTML     31K 
                Cash Flow Information Related to Leases (Details)                
17: R40         Commitments and Contingencies (Details Narrative)   HTML     31K 
43: R41         Commitments and Contingencies - Schedule of         HTML     42K 
                Current Contractual Obligations (Details)                        
61: R42         Equity Transactions (Details Narrative)             HTML     29K 
57: R43         Stock Options and Equity-Classified Warrants        HTML     60K 
                (Details Narrative)                                              
16: R44         Stock Options and Equity-Classified Warrants -      HTML     35K 
                Schedule of Share-based Payment Award, Fair Value                
                of the Stock Options Granted, Assumptions                        
                (Details)                                                        
42: R45         Stock Options and Equity-Classified Warrants -      HTML     68K 
                Schedule of Share-based Compensation, Stock                      
                Options, Activity (Details)                                      
60: R46         Stock Options and Equity-Classified Warrants -      HTML     60K 
                Schedule of Ranges of Stock Options (Details)                    
56: R47         Stock Options and Equity-Classified Warrants -      HTML     30K 
                Schedule of Total Stock-based Compensation Expense               
                from Stock Options (Details)                                     
15: R48         Stock Options and Equity-Classified Warrants -      HTML     52K 
                Schedule of Warrants Activity and Related                        
                Information (Details)                                            
44: R49         Stock Options and Equity-Classified Warrants -      HTML     61K 
                Schedule of Ranges of Warrants (Details)                         
39: R50         Stockholder Protection Rights Plan (Details         HTML     39K 
                Narrative)                                                       
30: R51         Income Taxes (Details Narrative)                    HTML     45K 
55: R52         Income Taxes - Schedule of Deferred Tax Assets and  HTML     43K 
                Liabilities (Details)                                            
71: R53         Income Taxes - Schedule of Effective Income Tax     HTML     54K 
                Rate Reconciliation (Details)                                    
40: R54         Subsequent Events (Details Narrative)               HTML     36K 
18: XML         IDEA XML File -- Filing Summary                      XML    122K 
41: EXCEL       IDEA Workbook of Financial Reports                  XLSX     66K 
 9: EX-101.INS  XBRL Instance -- cytr-20191231                       XML   1.03M 
11: EX-101.CAL  XBRL Calculations -- cytr-20191231_cal               XML    152K 
12: EX-101.DEF  XBRL Definitions -- cytr-20191231_def                XML    487K 
13: EX-101.LAB  XBRL Labels -- cytr-20191231_lab                     XML    900K 
14: EX-101.PRE  XBRL Presentations -- cytr-20191231_pre              XML    676K 
10: EX-101.SCH  XBRL Schema -- cytr-20191231                         XSD    148K 
31: ZIP         XBRL Zipped Folder -- 0001493152-20-004848-xbrl      Zip    116K

‘EX-101.SCH’   —   XBRL Schema — cytr-20191231

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
<!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
<!-- Field: Doc-Info; Name: Source; Value: 20191231 10K FY DFN.xfr; Date: 2020%2D03%2D27T03:32:04Z -->
<!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaeM2bP9z5Z8GekhvWB3bdna3yghV+XZcSArmjG2QesA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:CYTR="http://cytrx.com/20191231" elementFormDefault="qualified" targetNamespace="http://cytrx.com/20191231">
<annotation>
<appinfo>
<link:roleType roleURI="http://cytrx.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
<link:definition> 00000001 - Document - Document and Entity Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/BalanceSheets" id="BalanceSheets">
<link:definition> 00000002 - Statement - Consolidated Balance Sheets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
<link:definition> 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StatementsOfOperations" id="StatementsOfOperations">
<link:definition> 00000004 - Statement - Consolidated Statements of Operations </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StatementsOfStockholdersEquity" id="StatementsOfStockholdersEquity">
<link:definition> 00000005 - Statement - Consolidated Statements of Stockholders' Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
<link:definition> 00000006 - Statement - Consolidated Statements of Cash Flows </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/NatureOfBusiness" id="NatureOfBusiness">
<link:definition> 00000007 - Disclosure - Nature of Business </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition> 00000008 - Disclosure - Summary of Significant Accounting Policies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/DiscontinuedOperations" id="DiscontinuedOperations">
<link:definition> 00000009 - Disclosure - Discontinued Operations </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/ForeignCurrencyRemeasurement" id="ForeignCurrencyRemeasurement">
<link:definition> 00000010 - Disclosure - Foreign Currency Remeasurement </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/EquipmentAndFurnishings" id="EquipmentAndFurnishings">
<link:definition> 00000011 - Disclosure - Equipment and Furnishings </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/AccruedExpensesAndOtherCurrentLiabilities" id="AccruedExpensesAndOtherCurrentLiabilities">
<link:definition> 00000012 - Disclosure - Accrued Expenses and Other Current Liabilities </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/Leases" id="Leases">
<link:definition> 00000013 - Disclosure - Leases </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition> 00000014 - Disclosure - Commitments and Contingencies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/EquityTransactions" id="EquityTransactions">
<link:definition> 00000015 - Disclosure - Equity Transactions </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants" id="StockOptionsAndEquity-classifiedWarrants">
<link:definition> 00000016 - Disclosure - Stock Options and Equity-Classified Warrants </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StockholderProtectionRightsPlan" id="StockholderProtectionRightsPlan">
<link:definition> 00000017 - Disclosure - Stockholder Protection Rights Plan </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/IncomeTaxes" id="IncomeTaxes">
<link:definition> 00000018 - Disclosure - Income Taxes </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition> 00000019 - Disclosure - Subsequent Events </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
<link:definition> 00000020 - Disclosure - Summary of Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
<link:definition> 00000021 - Disclosure - Summary of Significant Accounting Policies (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/DiscontinuedOperationsTables" id="DiscontinuedOperationsTables">
<link:definition> 00000022 - Disclosure - Discontinued Operations (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/EquipmentAndFurnishingsTables" id="EquipmentAndFurnishingsTables">
<link:definition> 00000023 - Disclosure - Equipment and Furnishings (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" id="AccruedExpensesAndOtherCurrentLiabilitiesTables">
<link:definition> 00000024 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/LeasesTables" id="LeasesTables">
<link:definition> 00000025 - Disclosure - Leases (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
<link:definition> 00000026 - Disclosure - Commitments and Contingencies (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrantsTables" id="StockOptionsAndEquity-classifiedWarrantsTables">
<link:definition> 00000027 - Disclosure - Stock Options and Equity-Classified Warrants (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
<link:definition> 00000028 - Disclosure - Income Taxes (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/NatureOfBusinessDetailsNarrative" id="NatureOfBusinessDetailsNarrative">
<link:definition> 00000029 - Disclosure - Nature of Business (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
<link:definition> 00000030 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueMeasurementsByLevelForAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" id="SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueMeasurementsByLevelForAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails">
<link:definition> 00000031 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/DiscontinuedOperationsDetailsNarrative" id="DiscontinuedOperationsDetailsNarrative">
<link:definition> 00000032 - Disclosure - Discontinued Operations (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/DiscontinuedOperations-ScheduleOfDiscontinuedOperationsDetails" id="DiscontinuedOperations-ScheduleOfDiscontinuedOperationsDetails">
<link:definition> 00000033 - Disclosure - Discontinued Operations - Schedule of Discontinued Operations (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/ForeignCurrencyRemeasurementDetailsNarrative" id="ForeignCurrencyRemeasurementDetailsNarrative">
<link:definition> 00000034 - Disclosure - Foreign Currency Remeasurement (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/EquipmentAndFurnishingsDetailsNarrative" id="EquipmentAndFurnishingsDetailsNarrative">
<link:definition> 00000035 - Disclosure - Equipment and Furnishings (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/EquipmentAndFurnishings-ScheduleOfEquipmentAndFurnishingsDetails" id="EquipmentAndFurnishings-ScheduleOfEquipmentAndFurnishingsDetails">
<link:definition> 00000036 - Disclosure - Equipment and Furnishings - Schedule of Equipment and Furnishings (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/AccruedExpensesAndOtherCurrentLiabilities-ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" id="AccruedExpensesAndOtherCurrentLiabilities-ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
<link:definition> 00000037 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/LeasesDetailsNarrative" id="LeasesDetailsNarrative">
<link:definition> 00000038 - Disclosure - Leases (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/Leases-ScheduleOfRentExpenseAndSupplementalCashFlowInformationRelatedToLeasesDetails" id="Leases-ScheduleOfRentExpenseAndSupplementalCashFlowInformationRelatedToLeasesDetails">
<link:definition> 00000039 - Disclosure - Leases - Schedule of Rent Expense and Supplemental Cash Flow Information Related to Leases (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
<link:definition> 00000040 - Disclosure - Commitments and Contingencies (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/CommitmentsAndContingencies-ScheduleOfCurrentContractualObligationsDetails" id="CommitmentsAndContingencies-ScheduleOfCurrentContractualObligationsDetails">
<link:definition> 00000041 - Disclosure - Commitments and Contingencies - Schedule of Current Contractual Obligations (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/EquityTransactionsDetailsNarrative" id="EquityTransactionsDetailsNarrative">
<link:definition> 00000042 - Disclosure - Equity Transactions (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrantsDetailsNarrative" id="StockOptionsAndEquity-classifiedWarrantsDetailsNarrative">
<link:definition> 00000043 - Disclosure - Stock Options and Equity-Classified Warrants (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfShare-basedPaymentAwardFairValueOfStockOptionsGrantedAssumptionsDetails" id="StockOptionsAndEquity-classifiedWarrants-ScheduleOfShare-basedPaymentAwardFairValueOfStockOptionsGrantedAssumptionsDetails">
<link:definition> 00000044 - Disclosure - Stock Options and Equity-Classified Warrants - Schedule of Share-based Payment Award, Fair Value of the Stock Options Granted, Assumptions (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfShare-basedCompensationStockOptionsActivityDetails" id="StockOptionsAndEquity-classifiedWarrants-ScheduleOfShare-basedCompensationStockOptionsActivityDetails">
<link:definition> 00000045 - Disclosure - Stock Options and Equity-Classified Warrants - Schedule of Share-based Compensation, Stock Options, Activity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfRangesOfStockOptionsDetails" id="StockOptionsAndEquity-classifiedWarrants-ScheduleOfRangesOfStockOptionsDetails">
<link:definition> 00000046 - Disclosure - Stock Options and Equity-Classified Warrants - Schedule of Ranges of Stock Options (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfTotalStock-basedCompensationExpenseFromStockOptionsDetails" id="StockOptionsAndEquity-classifiedWarrants-ScheduleOfTotalStock-basedCompensationExpenseFromStockOptionsDetails">
<link:definition> 00000047 - Disclosure - Stock Options and Equity-Classified Warrants - Schedule of Total Stock-based Compensation Expense from Stock Options (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfWarrantsActivityAndRelatedInformationDetails" id="StockOptionsAndEquity-classifiedWarrants-ScheduleOfWarrantsActivityAndRelatedInformationDetails">
<link:definition> 00000048 - Disclosure - Stock Options and Equity-Classified Warrants - Schedule of Warrants Activity and Related Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfRangesOfWarrantsDetails" id="StockOptionsAndEquity-classifiedWarrants-ScheduleOfRangesOfWarrantsDetails">
<link:definition> 00000049 - Disclosure - Stock Options and Equity-Classified Warrants - Schedule of Ranges of Warrants (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StockholderProtectionRightsPlanDetailsNarrative" id="StockholderProtectionRightsPlanDetailsNarrative">
<link:definition> 00000050 - Disclosure - Stockholder Protection Rights Plan (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
<link:definition> 00000051 - Disclosure - Income Taxes (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" id="IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
<link:definition> 00000052 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" id="IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails">
<link:definition> 00000053 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
<link:definition> 00000054 - Disclosure - Subsequent Events (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="cytr-20191231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="cytr-20191231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="cytr-20191231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="cytr-20191231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links"/>
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
<import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>
<import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd"/>
<import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd"/>
<import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd"/>
<element id="CYTR_CommonStockMarketPricePremiumPercentage" name="CommonStockMarketPricePremiumPercentage" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_PercentageOfServiceCharge" name="PercentageOfServiceCharge" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_PaymentsForMilestone" name="PaymentsForMilestone" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_PreferredStockStatedValue" name="PreferredStockStatedValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" name="DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_DisposalGroupIncludingDiscontinuedOperationLossOnImpairmentOfEquipmentAndFurnishings" name="DisposalGroupIncludingDiscontinuedOperationLossOnImpairmentOfEquipmentAndFurnishings" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_DisposalGroupIncludingDiscontinuedOperationEmployeeStockOptionExpense" name="DisposalGroupIncludingDiscontinuedOperationEmployeeStockOptionExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_AccountingStandardsCodificationAdoption" name="AccountingStandardsCodificationAdoption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_AdjustmentsToAdditionalPaidInCapitalWarrantSharesIssued" name="AdjustmentsToAdditionalPaidInCapitalWarrantSharesIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_PreferredStockConversionValuePerShare" name="PreferredStockConversionValuePerShare" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_PaymentsForProceedsFromSaleOfPropertyPlantAndEquipment" name="PaymentsForProceedsFromSaleOfPropertyPlantAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_StockholderProtectionRightsPlanTextBlock" name="StockholderProtectionRightsPlanTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_PatentsAndPatentApplicationCostsPolicyTextBlock" name="PatentsAndPatentApplicationCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ClinicalTrialExpensesPolicyTextBlock" name="ClinicalTrialExpensesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ScheduleOfStockBasedCompensationExpenseFromStockOptionsTableTextBlock" name="ScheduleOfStockBasedCompensationExpenseFromStockOptionsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ScheduleOfRangesOfWarrantsTableTextBlock" name="ScheduleOfRangesOfWarrantsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_FutureMilestonePaymentReceivableUnderLicenseAgreement" name="FutureMilestonePaymentReceivableUnderLicenseAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ReductionInContractLiability" name="ReductionInContractLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_DisposalGroupIncludingDiscontinuedOperationPaymentsForLiabilities" name="DisposalGroupIncludingDiscontinuedOperationPaymentsForLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_AccruedResearchAndDevelopmentCosts" name="AccruedResearchAndDevelopmentCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_PotentialFutureMilestonePaymentsOnEachAdditionalFinalMarketingApproval" name="PotentialFutureMilestonePaymentsOnEachAdditionalFinalMarketingApproval" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ShareBasedCompensationSharesAuthorizedUnderNonOptionExercisePriceRangeLowerRangeLimit" name="ShareBasedCompensationSharesAuthorizedUnderNonOptionExercisePriceRangeLowerRangeLimit" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ShareBasedCompensationSharesAuthorizedUnderNonOptionExercisePriceRangeUpperRangeLimit" name="ShareBasedCompensationSharesAuthorizedUnderNonOptionExercisePriceRangeUpperRangeLimit" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumbers" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumbers" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsOtstandingWeightedAverageRemainingContractualTerms" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsOtstandingWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisableWeightedAverageRemainingContractualTerms" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisableWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_DeferredTaxValuationAllowancePercentage" name="DeferredTaxValuationAllowancePercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ChangeInDeferredTaxValuationAllowance" name="ChangeInDeferredTaxValuationAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_IncomeTaxReconciliationTaxStateCredits" name="IncomeTaxReconciliationTaxStateCredits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_IncomeTaxReconciliationWarrantLiabilities" name="IncomeTaxReconciliationWarrantLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_IncomeTaxReconciliationOtherPermanentDifferences" name="IncomeTaxReconciliationOtherPermanentDifferences" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_IncomeTaxReconciliationFederalRateAdjustment" name="IncomeTaxReconciliationFederalRateAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_IncomeTaxReconciliationNonQualifiedOptions" name="IncomeTaxReconciliationNonQualifiedOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_IncomeTaxReconciliationNetOperatinglossAdjustments" name="IncomeTaxReconciliationNetOperatinglossAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_IncomeTaxReconciliationReturnToProvision" name="IncomeTaxReconciliationReturnToProvision" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_NetLossBeforeIncomeTaxes" name="NetLossBeforeIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_CumulativeEffectAdjustment" name="CumulativeEffectAdjustment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ProtectionRightsPlanDescription" name="ProtectionRightsPlanDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_PreferredStockExercisePricePerShare" name="PreferredStockExercisePricePerShare" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_BeneficialOwnershipPercentageOfCompanyOutstandingSharesOfCommonStockByAcquiringPerson" name="BeneficialOwnershipPercentageOfCompanyOutstandingSharesOfCommonStockByAcquiringPerson" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_PercentageOfCompanyOutstandingSharesOfCommonStockByAcquisition" name="PercentageOfCompanyOutstandingSharesOfCommonStockByAcquisition" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_AnnualPercentageIncreasedInMonthlyRent" name="AnnualPercentageIncreasedInMonthlyRent" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_FederalOperatingLossCarryforward" name="FederalOperatingLossCarryforward" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_RentExpensesInContinuingOperations" name="RentExpensesInContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_RentExpensesInDiscontinuingOperations" name="RentExpensesInDiscontinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_SeriesAJuniorParticipatingPreferredStockMember" name="SeriesAJuniorParticipatingPreferredStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_EmployeesMember" name="EmployeesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_NonEmployeesMember" name="NonEmployeesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ManagementServicesAgreementMember" name="ManagementServicesAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_OrphazymeMember" name="OrphazymeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_EMAMember" name="EMAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_FDAMember" name="FDAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_LongTermIncentivePlanMember" name="LongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_StockIncentivePlanMember" name="StockIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_CurrentEmployeesMember" name="CurrentEmployeesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_StockOptionsMember" name="StockOptionsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ExercisePriceRangeOneMember" name="ExercisePriceRangeOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ExercisePriceRangeTwoMember" name="ExercisePriceRangeTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ExercisePriceRangeThreeMember" name="ExercisePriceRangeThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ExercisePriceRangeFourMember" name="ExercisePriceRangeFourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_NantCellLicensingAgreementMember" name="NantCellLicensingAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_FreiburgGermanyMember" name="FreiburgGermanyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_OfficeFurnitureAndLeaseholdImprovementsMember" name="OfficeFurnitureAndLeaseholdImprovementsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_StockOptionsRestrictedStockAndWarrantsMember" name="StockOptionsRestrictedStockAndWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_SeriesBJuniorParticipatingPreferredStockMember" name="SeriesBJuniorParticipatingPreferredStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_SeriesBConvertiblePreferredSharesMember" name="SeriesBConvertiblePreferredSharesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_EmployeesAndDirectorsMember" name="EmployeesAndDirectorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_NonEmployeeMember" name="NonEmployeeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_TwoThousandNineteenAndFirstQuarterOfTwoThousandTwentyMember" name="TwoThousandNineteenAndFirstQuarterOfTwoThousandTwentyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_FreiburgLabMember" name="FreiburgLabMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_OtherGeneralAndAdministrativeExpensesMember" name="OtherGeneralAndAdministrativeExpensesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_TwoThousandTwentyAndFirstQuarterOfTwoThousandTwentyOneMember" name="TwoThousandTwentyAndFirstQuarterOfTwoThousandTwentyOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ReimbursementAgreementMember" name="ReimbursementAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_AnalyticalEquipmentMember" name="AnalyticalEquipmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_AldoxorubicinMember" name="AldoxorubicinMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ArimoclomolMember" name="ArimoclomolMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_InnoviveMember" name="InnoviveMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_OperatingLeaseMember" name="OperatingLeaseMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_EmploymentAgreementsMember" name="EmploymentAgreementsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_EmployeesAndConsultantsMember" name="EmployeesAndConsultantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_TwoThousandNineteenStockIncentivePlanMember" name="TwoThousandNineteenStockIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ConsultantsMember" name="ConsultantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_WarrantOneMember" name="WarrantOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_WarrantTwoMember" name="WarrantTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_WarrantThreeMember" name="WarrantThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_WarrantFourMember" name="WarrantFourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_ShareHoldersMember" name="ShareHoldersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_StorageSpaceMember" name="StorageSpaceMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_StevenKriegsmanMember" name="StevenKriegsmanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="CYTR_StockholderProtectionRightsPlanAbstract" name="StockholderProtectionRightsPlanAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
</schema>

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/23/20  LadRx Corp.                       S-8        10/23/20    5:265K                                   M2 Compliance LLC/FA
↑Top
Filing Submission 0001493152-20-004848   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., May 4, 8:25:44.1pm ET